1781226-44-5
![2,6-Dihydroxyacetophenone-4-O-[4,6-(S)-hexahydroxydiphenoyl]-β-D-glucose Chemical Structure](http://file.medchemexpress.cn/product_pic/hy-n8032.gif "2,6-Dihydroxyacetophenone-4-O-[4,6-(S)-hexahydroxydiphenoyl]-β-D-glucose Chemical Structure")
Chemical Structure
2,6-Dihydroxyacetophenone-4-O-[4,6-(S)-hexahydroxydiphenoyl]-β-D-glucose
- CAS No.: 1781226-44-5
- Formula:C28H24O17
- Molecular Weight:632.48
IUPAC Name: (11aR,13S,14R,15R,15aS)-13-(4-acetyl-3,5-dihydroxyphenoxy)-2,3,4,5,6,7,14,15-octahydroxy-11,11a,13,14,15,15a-hexahydrodibenzo[g,i]pyrano[3,2-b][1,5]dioxacycloundecine-9,17-dione
InChIKey: PFJCKKBMOOGJSX-IJKWSERMSA-N
SMILES: CC(C1=C(O)C=C(O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](COC3=O)O2)OC(C4=CC(O)=C(O)C(O)=C4C5=C(O)C(O)=C(O)C=C53)=O)O)O)C=C1O)=O
Biological Activity: 2,6-Dihydroxyacetophenone-4-O-[4,6-(S)-hexahydroxydiphenoyl]-β-D-glucose is a novel polyphenol/ellagitannin-type glucoside. 2,6-Dihydroxyacetophenone-4-O-[4,6-(S)-hexahydroxydiphenoyl]-β-D-glucose mediates antiproliferative effects via platelet-derived growth factor (PDGF)-induced hepatic stellate cells. 2,6-Dihydroxyacetophenone-4-O-[4,6-(S)-hexahydroxydiphenoyl]-β-D-glucose can be used for the research of hepatic fibrosis[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
2,6-Dihydroxyacetophenone-4-O-[4,6-(S)-hexahydroxydiphenoyl]-β-D-glucose | 2,6-Dihydroxyacetophenone-4-O-[4,6-(S)-hexahydroxydiphenoyl]-β-D-glucose is a novel polyphenol/ellagitannin-type glucoside. 2,6-Dihydroxyacetophenone-4-O-[4,6-(S)-hexahydroxydiphenoyl]-β-D-glucose mediates antiproliferative effects via platelet-derived growth factor (PDGF)-induced hepatic stellate cells. 2,6-Dihydroxyacetophenone-4-O-[4,6-(S)-hexahydroxydiphenoyl]-β-D-glucose can be used for the research of hepatic fibrosis. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
